Gt Biopharma, Inc. · NASDAQ:GTBP

Bristol Capital, LLC reported a 4.76% stake in Gt Biopharma, Inc. (Schedule 13G/A)

Event May 29, 2025 · Filed Jun 2, 2025

Bristol Capital, LLC reported a 4.76% stake in Gt Biopharma, Inc., 0 shares, as a passive investor on May 29, 2025. Filed Jun 2, 2025 (Schedule 13G/A).

Stake
4.76%
Shares
0
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Bristol Investment Fund, Ltd.2.37%74,524
Bristol Capital, LLC4.76%0

Source

View original at SEC

Related